FARN — Faron Pharmaceuticals Oy Share News
0.000.00%
Approval of Share Subscriptions Based on Special Rights in connection with Advanced Amortisation of the First Tranche Bonds
Holding(s) in Company
Registration of New Shares
Approval of Share Subscriptions Based on Special Rights in connection with Amortisation of the First Tranche Bonds
Grant of Options
Brief: Faron Pharmaceuticals Appoints CFO
Appointment of CFO
Approval of Share Subscriptions Based on Special Rights in connection with Advanced Amortisation of the First Tranche Bonds
HOLDING(S) IN COMPANY
Brief: Faron Enters Into Up To EUR 35 Million Convertible Bond Arrangement
Brief: Faron Pharmaceuticals Says FDA Grants Orphan Drug Designation
Faron Pharma. Oy - FDA Grants Orphan Drug Designation
Faron Pharma. Oy - Notice of Annual General Meeting
Advisory: Dated alert on Faron Pharmaceuticals' appointment of CEO, CFO withdrawn
Faron Pharma. Oy - Annual Report 2024 published
Faron Pharma. Oy - Financial Statement 1 January to 31 December 2024
Faron Pharma. Oy - Notice of Financial Statement and Annual Report
Faron Pharma. Oy - Holding(s) in Company
Faron Pharma. Oy - Holding(s) in Company